CIGI MATHEW: Open Payments
NPI 1013246529 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 8 payments from 8 companies in 2025. Trend: 2023 $677 · 2024 $819 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| bioMerieux Inc | 1 | $142 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| UCB, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Viatris Specialty LLC | 1 | $122 |
| Sage Therapeutics, LLC | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $65 |
| Axsome Therapeutics, Inc. | 1 | $35 |
Products named: BIOFIRE RESPIRATORY PANEL 2.1, Nayzilam, ENTYVIO, YUPELRI, FASENRA, Auvelity.
Industry payments across NY — which companies pay providers there.
